Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00752_DB01278_nanopub.RABrw8Q1RT3RugGxY8BbZFnknQHHBRXx8J19Xiimtp1gw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00752_DB01278 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00752_DB01278 label "DDI between Tranylcypromine and Pramlintide - The anticholinergic effects of Tranylcypromine may be enhanced by Pramlintide. Additive effects of reduced GI motility may occur. Pramlintide slows gastic emptying and should not be used with drugs that alter GI motility (e.g. anticholinergics). Consider alternative treatments or use caution during concomitant therapy. [drugbank_resource:DB00752_DB01278]" assertion.
- drugbank_resource:DB00752_DB01278 identifier "drugbank_resource:DB00752_DB01278" assertion.
- drugbank_resource:DB00752_DB01278 title "DDI between Tranylcypromine and Pramlintide - The anticholinergic effects of Tranylcypromine may be enhanced by Pramlintide. Additive effects of reduced GI motility may occur. Pramlintide slows gastic emptying and should not be used with drugs that alter GI motility (e.g. anticholinergics). Consider alternative treatments or use caution during concomitant therapy." assertion.
- drugbank:DB00752 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00752_DB01278 assertion.
- drugbank:DB01278 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00752_DB01278 assertion.